| Financial Year |
March 31 2023 |
| Monetary Funds |
132,617,532.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
21,569,203.47 |
| Accounts Receivable |
177,617,496.38 |
| Advances to Suppliers |
10,848,981.00 |
| Other Receivables |
1,766,896.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,786,856.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,104,599.23 |
| Total Current Assets |
525,554,546.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
168,252,915.83 |
| Under-construction Projects |
221,108,148.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,314,086.26 |
| R&D expenses |
-- |
| Goodwill |
10,670,774.32 |
| Long-Term Deferred and Prepaid Expenses |
12,263,352.28 |
| Deferred Income Tax Assets |
21,769,935.22 |
| Other Non-Current Assets |
69,696,384.86 |
| Sub-Total of Non-Current Assets |
570,342,433.66 |
| Total Assets |
1,095,896,980.43 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
468,984.00 |
| Notes Payable |
30,531,220.87 |
| Accounts Payable |
203,172,059.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,331,264.99 |
| Taxes Payable |
2,365,693.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
221,546.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
18,323,299.23 |
| Sub-Total of Current Liabilities |
266,607,540.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
729,506.50 |
| Total Liabilities |
267,337,046.86 |
| Paid-In Capital(Or Share Stock) |
105,054,800.00 |
| Capital Surplus |
435,470,397.95 |
| Surplus Reserve |
24,661,041.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
242,946,514.09 |
| Minority Stockholder's Interest |
20,033,082.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
808,526,850.88 |
| Owner's Equity（Stockholder's Equity） |
828,559,933.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,095,896,980.43 |
